The Vaxil Team

Mr. Gadi Levin – Chairman of the Board, CEO

Mr. Levin has 20 years’ experience working with US, Canadian and multi-jurisdictional publicly listed companies. He currently serves as a director and CFO of a few publicly listed companies.

Mr. Levin began his career at the accounting firm, Arthur Andersen, where he worked for nine years, specializing in NYSE/NASDAQ listed companies, IPO’s, start-up’s, US GAAP and IFRS.

He has a Bachelor of Commerce degree in Accounting and Information Systems from the University of the Cape Town, South Africa, and a post graduate diploma in Accounting from the University of South Africa. He received his Chartered Accountant designation in South Africa and has an MBA from Bar Ilan University in Israel..

Dr. Ari S. Kellen, M.D. – Director

Dr. Ari Kellen is an experienced senior executive with over three decades of healthcare industry experience. After practicing medicine and running a large segment of the Johannesburg Hospital in South Africa, Dr. Kellen was recruited to McKinsey & Company where he spent 22 years as a strategic advisor to boards of directors and CEOs of major health care clients across the globe.

In 2014 Dr. Kellen was recruited to Valeant Pharmaceuticals. Running US Bausch + Lomb, R&D, Latin America and Dermatology, he helped lead the company through a challenging period involving a change in leadership and business strategy, and was subsequently promoted by the new CEO and Board to the global segment leader of Bausch + Lomb.

Since 2017 Dr. Kellen has been serving as a strategic advisor and investor to early-stage innovative healthcare companies in the US, Europe, and Israel. He serves on the boards of Theraclion and Vaxil Bio, and is a strategic advisor to several other companies including BioNanoSim and Nouri Life. Dr Kellen is a graduate of the University of the Witwatersrand in South Africa where he received his Medical and MBA degrees with distinction

Dr. Shawn Langer, M.D. – Director

Dr. Shawn Langer brings over two decades of healthcare industry experience. Dr. Langer was Senior Partner at McKinsey & Company, where he was the leader of its Healthcare Private Equity Group.

During his 15 years with McKinsey & Company, Dr. Langer served healthcare clients across pharmaceuticals, biotechnology, medical devices, and healthcare services.

Most recently Dr. Langer has spent nearly 5 years investing in innovative healthcare companies in his capacity as a portfolio manager at healthcare private equity investment firm BMHS Investments.

Dr. Langer holds an MD from the University of Toronto.

Mr. Daniel Bloch – Director

Mr. Bloch has a been an attorney licensed in Canada since 1998. He currently is the owner of Bloch Legal, a firm that specializes in International commercial transactions and Canadian listed company corporate legal and strategic advisory services.

Mr. Bloch has a Bachelor of Business Administration from York University (Toronto, Ontario, Canada) and a Bachelor of Law degree (LLB) from the University of Victoria (Victoria, British Columbia, Canada).

Mr. Alan Rootenberg – CFO

Mr. Rootenberg is a chartered professional accountant who has served as the Chief Financial Officer of a number of publicly traded companies listed on the TSX, TSX Venture Exchange, OTCBB and CSE. These companies include mineral exploration, mining, technology and cannabis companies.

Mr. Rootenberg has a Bachelor of Commerce degree from the University of the Witwatersrand in Johannesburg, South Africa and received his CPA designation in Ontario, Canada.